Emboline
PrivateLast Round
Debt
Mar 11, 2026
Total Funding Raised
$107M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Emboline is a medical device company that develops an embolic protection catheter to safeguard the arterial bed during percutaneous heart valve repair and replacement procedures by capturing and removing emboli to protect critical organs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emboline Comparables
Compare Emboline with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transverse Medical | 92% | |
| Filterlex Medical | 92% | |
| Protembis GmbH | 91% |
Emboline Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 11, 2026 | ||||
| Series D | May 25, 2021 | ||||
| Series C | Jan 5, 2021 | ||||
| Corporate Funding | Jan 31, 2020 | ||||
| Series B | Apr 19, 2018 |
Key People
Founding team and executive leadership
Emboline Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Trinity Capital | Debt |
| SV Tech Ventures | Series D, Series B |
| Matrix Capital Management | Series D |
| SV Tech | Series D |
| ShangBay Capital | Series D, Series B |
| Global Assets Investment, LLC | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 601% MoM, from 374 to 2.6K.
- May 17, 2026
Monthly visitors grew 65% MoM, from 1K to 1.7K.
Emboline Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access